AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.225
- -0.015-6.25%
20min DelayMarket Closed Oct 18 15:46 AET
109.49MMarket Cap-10714P/E (Static)
0.240High0.225Low573.86KVolume0.240Open0.240Pre Close133.98KTurnover0.24552wk High0.16%Turnover Ratio486.63MShares0.22052wk Low-0.021EPS TTM81.12MFloat Cap0.245Historical HighLossP/E (Static)360.54MShs Float0.220Historical Low-0.021EPS LYR6.25%Amplitude--Dividend TTM10.71P/B1Lot Size--Div YieldTTM
About Neurizon Therapeutics Ltd Company
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).
Company Profile
SymbolNUZ
Company NameNeurizon Therapeutics Ltd
Founded2000
MarketASX
Employees52
Fiscal Year Ends06-30
Address96-100 Albert Road Level 4
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396927222
Websitehttps://www.neurizon.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Level 17, 221 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 850 505
Company Executives
- Name
- Position
- Salary
- Michael Thurn
- Chief Executive Officer,Managing Director
- --
- Sergio Duchini
- Non-Executive Chairman,Non-Executive Director
- --
- Marcus Hughes
- Non-Executive Director
- --
- Kathryn(Katie) MacFarlane
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data